- 专利标题： MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT
-
申请号： US11759413申请日： 2007-06-07
-
公开(公告)号： US20080057120A1公开(公告)日： 2008-03-06
- 发明人: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
- 申请人： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
- 申请人地址： BB St. Michael
- 专利权人： BIOAVAIL LABORATORIES INTERNATIONAL S.R.L.
- 当前专利权人： BIOAVAIL LABORATORIES INTERNATIONAL S.R.L.
- 当前专利权人地址： BB St. Michael
- 主分类号： A61K9/20
- IPC分类号： A61K9/20 ; A61P25/00 ; C07C211/00
摘要：
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
公开/授权文献
- US07649019B2 Modified release formulations of a bupropion salt 公开/授权日：2010-01-19
信息查询
